Goa-based Molbio Diagnostics, backed by Temasek and MOPE, has filed its DRHP with SEBI for an IPO comprising a fresh issue of ₹200 crore and an OFS of 1.25 crore equity shares. The funds will be utilized for R&D infrastructure, manufacturing expansion, and corporate purposes.
